CMS reveals 34 Medicare drugs subject to inflation rebates under IRA next quarter

The fed­er­al gov­ern­ment has re­leased the lat­est round of Medicare coin­sur­ance sav­ings un­der the In­fla­tion Re­duc­tion Act’s re­bate pro­gram.

The leg­is­la­tion en­act­ed last sum­mer re­quires re­bates to Medicare on cer­tain drugs with prices ris­ing faster than the rate of in­fla­tion. A to­tal of 34 Part B drugs will have ad­just­ed coin­sur­ance rates for the Oct. 1 to Dec. 31 pe­ri­od, re­sult­ing in sav­ings for se­niors be­tween $1 and $618 per av­er­age dose, ac­cord­ing to CMS, high­er than last quar­ter’s max­i­mum $449 per av­er­age dose de­spite a slight­ly short­er list.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.